Iberis gibraltarica
Iberis gibraltarica · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Iberis gibraltarica is a unique botanical species that has gained significant attention for its potential therapeutic applications. Recent scientific investigations have focused on its remarkable anticancer and antiviral activities. Specifically, research has explored its efficacy in addressing conditions such as hepatocellular carcinoma. Studies often analyze the plant's biological potency through the measurement of total crude protein and total protein content. Understanding these biochemical properties is essential for unlocking the plant's full medicinal potential.
- Synonyms
- Iberis Speciosa · Iberis Gibraltarica F. Hosmariensis · 3 more
- Common names
- Not available
- Family
- Brassicaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Iberis gibraltarica is a unique species widely recognized by its most popular common name, the Gibraltar candytuft. Depending on the region and local language, this plant is also referred to as Gibraltarinė rudgrūdėlė or Iberis de Gibraltar. Some enthusiasts and specialists may even use the specific designation gibraltariberis to describe it. These diverse naming conventions highlight the plant's varied presence across different botanical contexts. Understanding these multiple identities helps gardeners and botanists alike identify this lovely flowering species.
Sources: Catalogue of Life (COL)
Synonyms
Iberis gibraltarica is a botanical species known to encompass several taxonomic synonyms within its classification. Researchers frequently refer to this plant by its alternative name, Iberis dentata, depending on the specific study. The species also includes various forms and varieties, such as Iberis gibraltarica f. hosmariensis and the distinct Iberis gibraltarica var. glabrata. Further botanical distinctions are noted through the varieties var. pubescens and the synonym Iberis speciosa. Understanding these overlapping names is essential for accurate identification in both field studies and formal botanical records.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Iberis gibraltarica is a distinctive member of the kingdom Plantae. This botanical specimen belongs to the genus Iberis, which defines its unique structural characteristics. Within this genus, it is classified under the order Brassicales. Further narrowing its biological lineage, the plant is situated within the family Brassicaceae. Ultimately, its formal classification is completed by its placement in the class Equisetopsida.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Brassicaceae |
| Genus | Iberis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Iberis gibraltarica is a distinctive plant species with a geographically diverse distribution. Its natural range extends across parts of Africa, specifically within Northern Africa and Morocco. Additionally, the species is well-established throughout Europe, with a notable presence in Southwestern Europe. Within this region, Spain serves as a key location for its growth and survival. This wide-reaching habitat highlights the plant's ability to thrive in varied Mediterranean climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Iberis gibraltarica is characterized by its distinct herb growth form. This species functions as a self-supporting plant, maintaining its structure independently within its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Iberis gibraltarica has demonstrated significant therapeutic potential through its dual antiviral and anticancer activities. Recent studies focusing on its total crude protein have revealed a notable ability to reduce Hepatitis C virus (HCV) titers by up to 66% in a dose-dependent manner. Beyond its antiviral effects, the plant also shows promise in combating hepatocellular carcinoma (HCC) by inhibiting key cancer markers. Specifically, treatment with the protein extract led to a substantial 90% down-regulation of the AFP and GPC3 genes in HepG2 cells. These in vitro results suggest that Iberis gibraltarica could serve as a valuable resource in the future development of treatments for liver-related diseases.
Compounds
Conditions
Iberis gibraltarica demonstrates significant therapeutic potential in treating both the Hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) through its total crude protein. In vitro studies reveal that this plant extract can reduce HCV viral titers by up to 66% in a dose-dependent manner. Additionally, the protein from Iberis gibraltarica exhibits potent anticancer characteristics by inhibiting key HCC markers. Specifically, it causes up to a 90% down-regulation in the expression of the AFP and GPC3 genes within HepG2 cells. These findings highlight the plant's dual capacity to act as both an antiviral and an anticancer agent against these liver-related conditions.
Preparations
Iberis gibraltarica is prepared as total crude protein for the purpose of investigating its antiviral and anticancer properties. This specific preparation, identified as total protein, was isolated and quantified to assess its effects on Hepatitis C virus and hepatocellular carcinoma. Research indicates that the total crude protein extracted from the plant can reduce viral titers in a dose-dependent manner. Furthermore, the total protein of Iberis gibraltarica demonstrates significant potential in down-regulating the expression of specific cancer markers. Consequently, the plant is processed into these protein forms to explore its therapeutic capabilities in vitro.